Dr. Jaworski coordinates clinical activities for the Poison Control Center to ensure optimal poison information and toxicology support to the community's patients and providers. He also serves as the Poison Control’s liaison to the Pharmacy Department and Medication Safety Officer.
Pharmacy Residency (PGY-1) - Henry Ford Hospital, Detroit, MI
Critical Care Specialty (PGY-2) - West Virginia University Medicine, Morgantown, WV
Doctor of Pharmacy - Wayne State University, Detroit, MI
Clinical Program Manager, Poison Control Center
Public health
Substance-use disorders
Toxicology
Hurth KP, Jaworski A, Thomas KB, Kirsch WB, Rudoni MA, Wohlfarth KM. “The re-emergence of ketamine for treatment in critically-ill adults.” Critical Care Medicine. 2020;48(6):899-911.
Zygowiec J, Solomon S, Jaworski A, Gotlib A, Bloome M. “25C NBOMe ingestion.” Clinical Practice and Cases in Emergency Medicine. 2017;1(4):295-7.
Carreno JJ, Jaworski A, Kenney RM, Davis SL. “Comparative incidence of nephrotoxicity by age group among adult patients receiving vancomycin.” Infectious Diseases and Therapy. 2013;2:201-8.
Hofman M, Jaworski A, Trella J, Osterhoudt K. IV acetaminophen overdose: cases in the American Association of Poison Control Centers’ National Poison Data System, 2017 to 2021. Abstract No 38. North American Congress of Clinical Toxicology 2022, San Francisco, CA, September 2022.
McElroy N, Trella J, Jaworski A. Variables impacting follow-up rates for healthcare facility referral at a Poison Control Center. Abstract No 273. North American Congress of Clinical Toxicology 2022, San Francisco, CA, September 2022.
Jaworski A, Longo L, Trella J, Osterhoudt KC. “Pediatric suicide attempts by poisoning: a five-year investigation of poison center data.” Abstract No. 1181653. Pediatric Academic Societies 2022, Denver, CO, April 2022.
Spetz SL, Jaworski A, Rudoni MA, Wohlfarth K. “Impact of hyperchloremia on renal and intensive care unit outcomes in traumatic brain injuries.” Abstract No. 731. Society of Critical Care Medicine Annual Congress, Orlando, FL, February 2020.
Cheng Y, Jaworski A, Rudoni MA, Wohlfarth K. “Clinical safety and efficacy of prolonged intravenous administration of lacosamide.” UAN: 0048-0000-18-107-L01-P. Ohio Pharmacy Residency Conference, Ada, OH, April 2018.
American Academy of Clinical Toxicology (AACT)
American Association of Poison Control Centers (AAPCC)
American Society of Health-System Pharmacists (ASHP)